leuvectin

leuvectin

Oncology An agent for treating metastatic melanoma, renal cell carcinoma, and sarcoma
References in periodicals archive ?
Vical's two lead product candidates, Allovectin-7 and Leuvectin, both involve direct injection of genetic material into tumors or surrounding tissue using lipids to facilitate delivery.
Leuvectin, which uses a lipid-DNA complex to stimulate an immune response against cancer cells, is in Phase II testing in patients with prostate cancer.
We believe this patent , which covers the use of gene-based IL-2 therapy for all tumor types, broadens our protection of potential market exclusivity for Leuvectin.